Novo Nordisk threatens legal action over Hims Wegovy copy (updated) Kimberly Redmond 6, 2026// The basics: Novo Nordisk warns Hims & Hers over $49 compounded, copycat version of Wegovy Drugmaker says product infringes on its branded GLP-1 treatment Hims offering lower-cost compounded weight-loss alternatives amid soaring demand Dispute highlights growing tension between brand-name pharma, telehealth platforms Novo Nordisk vowed to take legal action against Hims & Hers after the telehealth platform launched a cheaper, copycat version of the pharmaceutical giants Wegovy GLP-1 weight loss pill
Product leaves your skin clean and smooth
Metabolic markers including triglycerides have often improved
EClinicalMedicine 2024;73:102661.ArticlePubMedPMC 6
LH: Formal analysis, Resources, Writing review & editing, Methodology, Project administration, Writing original draft
If someone has a serious B12 shortage, it might take several doses to feel energized again
